Answers are grounded in this paper and cite their sources.
While point-of-care (POC) biosensors have enormous potential to help guide and inform clinical decisions at a patient's location, the translation of fundamental, applied, and proof-of-concept biosensors into commercial products is complex.
No takes yet. Share an insight, caveat, or question.
D’Alton et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: